1. Home
  2. CYTK vs BBWI Comparison

CYTK vs BBWI Comparison

Compare CYTK & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • BBWI
  • Stock Information
  • Founded
  • CYTK 1997
  • BBWI 1963
  • Country
  • CYTK United States
  • BBWI United States
  • Employees
  • CYTK N/A
  • BBWI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • BBWI Clothing/Shoe/Accessory Stores
  • Sector
  • CYTK Health Care
  • BBWI Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • BBWI Nasdaq
  • Market Cap
  • CYTK 5.6B
  • BBWI 6.1B
  • IPO Year
  • CYTK 2004
  • BBWI N/A
  • Fundamental
  • Price
  • CYTK $32.43
  • BBWI $28.25
  • Analyst Decision
  • CYTK Buy
  • BBWI Buy
  • Analyst Count
  • CYTK 14
  • BBWI 18
  • Target Price
  • CYTK $70.92
  • BBWI $41.76
  • AVG Volume (30 Days)
  • CYTK 1.3M
  • BBWI 6.1M
  • Earning Date
  • CYTK 08-07-2025
  • BBWI 05-29-2025
  • Dividend Yield
  • CYTK N/A
  • BBWI 2.84%
  • EPS Growth
  • CYTK N/A
  • BBWI N/A
  • EPS
  • CYTK N/A
  • BBWI 3.74
  • Revenue
  • CYTK $19,218,000.00
  • BBWI $7,347,000,000.00
  • Revenue This Year
  • CYTK $18.02
  • BBWI $4.30
  • Revenue Next Year
  • CYTK $737.32
  • BBWI $2.76
  • P/E Ratio
  • CYTK N/A
  • BBWI $7.51
  • Revenue Growth
  • CYTK 412.21
  • BBWI N/A
  • 52 Week Low
  • CYTK $29.31
  • BBWI $24.94
  • 52 Week High
  • CYTK $61.38
  • BBWI $42.63
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 46.32
  • BBWI 50.07
  • Support Level
  • CYTK $32.02
  • BBWI $24.94
  • Resistance Level
  • CYTK $34.72
  • BBWI $26.43
  • Average True Range (ATR)
  • CYTK 1.30
  • BBWI 0.97
  • MACD
  • CYTK 0.26
  • BBWI 0.16
  • Stochastic Oscillator
  • CYTK 45.08
  • BBWI 99.40

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.

Share on Social Networks: